China Medical Market is Expected to Grow by 20%
date：2010-04-16
browse：（431）
Keyword：
Herbridge,16 April 2010-Generic active pharmaceutical ingredients will enjoy a compound annual growth rate of 14% in China,India,Latin America and Central & Eastern Europe in the coming four years.Active pharmaceutical ingredients (API) export is expected to witness 15% growth in China in 2010.The medical market will probably increase by over twenty percent this year. said Tan Shengcai,deputy secretary general, China Chamber of Commerce for I/E of Medicines and Health Products(CCCMHPIE).
At present,China medical market value reaches $24.5 billion, ranking tenth in the World. Industry inside predicted that as the new medical reform progresses,China medical market value will reach over $70 billion,only outpaced by US and Japan.
At present,China medical market value reaches $24.5 billion, ranking tenth in the World. Industry inside predicted that as the new medical reform progresses,China medical market value will reach over $70 billion,only outpaced by US and Japan.
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
